Electrophysiology & Arrhythmia | March 2020

A patient’s e-cigarette interfered with their implantable cardioverter-defibrillator (ICD) and prevented the device from properly functioning, according to a new analysis published in HeartRhythm Case Reports.

On a biweekly basis, researchers and physicians at the Feinstein Institutes for Medical Research and North Shore University Hospital in New York gather to watch footage of patient resuscitations.

Nearly a quarter of older patients with atrial fibrillation receive inappropriately dosed direct-acting oral anticoagulants, according to an analysis of the ongoing SAGE-AF study.

A new analysis of the CASTLE-AF trial has found that catheter ablation for AFib remains effective in a much larger group of heart failure patients, cementing evidence first presented in early 2018.

A small-scale study published in Circulation March 3 has revealed a potential new culprit behind sudden cardiac death in patients with arrhythmogenic right ventricular cardiomyopathy: integrin β1D.

Researchers at Imperial College London have developed a new type of sensor that can track vital signs in both humans and animals, suggesting the ever-growing wearables trend is expanding to include pets and livestock.

Pulsed field ablation technology has been used to treat atrial fibrillation for the first time in the U.S.

A study published Feb. 25 in Circulation suggests wearables are useful for detecting CV abnormalities like atrial fibrillation, but there’s still a long way to go before they can be trusted for clinical management.